UTI vs APEI

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 02, 2026

UTI

53.0
AI Score
VS
UTI Wins

APEI

48.2
AI Score

Investment Advisor Scores

UTI

53score
Recommendation
HOLD

APEI

48score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric UTI APEI Winner
Revenue 442.25M 174.74M UTI
Net Income 13.26M 17.73M APEI
Net Margin 3.0% 10.1% APEI
Operating Income 16.03M 21.64M APEI
ROE 3.9% 5.8% APEI
ROA 1.6% 3.3% APEI
Total Assets 852.18M 537.91M UTI
Debt/Equity 0.38 0.29 APEI
Current Ratio 1.17 2.98 APEI
Free Cash Flow -45.59M 60.78M APEI

Relative Price Performance (Last 90 Days)

UTI 1M: -16.4% · 3M: +4.7% APEI 1M: -13.2% · 3M: -16.6%

Current Technical Phase

UTI

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 45

RSI (14): 45.1 · Price: $39.31

APEI

Markdown
Sell / avoid

Price below a falling SMA50 (slope -2.6%), weak momentum, RSI 41

RSI (14): 40.6 · Price: $48.51

Fundamentals Snapshot

Metric UTI APEI
Market Cap
Forward P/E 46.2 12.9
Trailing P/E 54.1 26.5
Revenue (TTM)
Revenue Growth 0.1% 0.1%
Gross Margin 0.6% 0.5%
Operating Margin 0.0% 0.1%
EPS 0.74 1.87
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, UTI is currently the stronger investment candidate, winning 2 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.